6th American Conference on Pharmacometrics (ACoP6)
“Enabling Environments in Which Pharmacometrics and Biostatistics Help Produce Robust Development and Regulatory Strategies”
Co-chairs: Vikram Sinha (FDA) and Brian Smith (Novartis)
October 4th, 2015 in Arlington, Virginia
This preconference meeting will address the role and scope of modeling and simulation (M&S) throughout the drug development process with a focus on the role of pharmacometrics and biostatistics. Challenges faced by pharmacometricians and statisticians regarding modeling and simulation in drug development and strategies to foster and advance appropriate use of modeling and simulation across disciplines will be discussed.
Specific use of M&S in the following areas will be discussed:
Speakers will include experts from pharmacometrics and biostatistics from industry, regulatory agencies and academia. The format will be brief presentations on the following topics and a panel discussion on specific topics with three panel sessions.